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Purpose: We quantified and described the economic burden of overactive bladder and stress urinary incontinence in Korea. We 
calculated direct costs by identifying public and private data sources that contain population-based data on resource utilization 
by patients with stress urinary incontinence and overactive bladder. 
Methods: For estimating indirect costs (productivity loss), the human capital approach was applied. Data were collected from 
several institutes, including the Health Insurance Review Agency.
Results: The estimated total economic cost in treating overactive bladder was 117 billion Korean Won (KRW, the currency of 
South Koea) in 2006 and 145 billion KRW in 2007. The estimated total cost in treating stress urinary incontinence was 122 bil-
lion KRW in 2006 and 59 billion KRW in 2007. 
Conclusions: By quantifying the total economic costs of overactive bladder and stress urinary incontinence, this study provides 
an important perspective in Korea. Because the average age of the Korean population is rapidly increasing, this study provides 
important information on the direct and indirect costs of overactive bladder and stress urinary incontinence for an aging soci-
ety.
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INTRODUCTION
Overactive bladder (OAB) and stress urinary incontinence (SUI) 
are two of the most common voiding related disorders. Urinary 
incontinence (UI) is defined as involuntary urinary leakage 
without reference to the causes of incontinence, and SUI is uri-
nary incontinence which is induced by increasing abdominal 
pressure [1]. The prevalence of UI is 24.3% in Korean women. 
OAB represents 48.8% of urinary incontinence patients, and is 
the most common disabling condition among urinary inconti-
nence patients [2].
  OAB is characterized by urgency_a sudden compelling de-
sire to pass urine that is difficult to defer. It is usually accompa-
nied by frequency and nocturia, and it may occur with urge in-
continence [1]. OAB affects 12.2% of the adult population in 
Korea, or approximately 3.5 million individuals, and the preva-
lence increases with advancing age [3].
  When the population aged 65 or over accounts for 7% of the 
total population, the country is defined as an aging society; 
when the elderly account for 14%, the nation is regarded as an 
aged society, and when the elderly account for 20%, the nation 
is regarded as a super-aged society. Korea will become an aged 
society by 2018, after first being identified as an aging society in 
2000. Moreover, Korea is expected to be a super-aged society in 
2026. Korea has been aging at one of the world’s fastest rates [4].
  The prevalences of OAB and SUI increase with advancing 
age, and the rapid increase of an aged population is associated 
with tremendous costs [2,3]. The purpose of this study is to es-
timate the economic costs of OAB and SUI by taking into ac-
count the direct costs and value of productivity loss in the Ko-
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rean population. By quantifying the total economic burden of 
OAB and SUI on a society, healthcare resources can be allocat-
ed appropriately.
MATERIALS AND METHODS
We calculated the costs by identifying public and private data 
sources that contain population-based data on resource utiliza-
tion by patients with SUI and OAB. Data sources were collected 
from several institutions, including the Health Insurance Re-
view Agency.
Estimation Framework
To determine the economic costs of any illness, three types of 
costs should be considered: direct costs, indirect costs (produc-
tivity loss), and intangible costs.
  The direct costs include medical expenditures (physician visit 
cost, admission cost, surgery, behavioral therapy, and pharma-
cologic therapy) and traffic costs. The direct medical cost is the 
annual cost required to treat SUI and OAB. Data from the 2006, 
2007 Medical Aid Statistical Yearbook and 2006, 2007 National 
Health Insurance Statistical Yearbook were used for the estima-
tion of outpatient and inpatient medical expenditures [5-8].
  Traffic cost belongs to direct non-medical cost. The average 
round-trip traffic cost which was 8,350 Korean Won (KRW, the 
currency of South Koea) for outpatient visit and 21,200 KRW 
for admission in 2005 [9]. These estimations were adjusted by 
2006, 2007 traffic price index, and the average round-trip traffic 
cost for outpatient visit was 8,768 KRW in 2006 and 9,018 
KRW in 2007. And the average round-trip traffic cost for ad-
mission was 22,260 KRW in 2006 and 22,896 KRW in 2007. 
The resulting average traffic cost was estimated in this way.
  In summary, Direct cost was estimated by following equa-
tion;
Direct costs=∑a(E
a+OE
a)+∑a{(O
a×MO)+(N
a×M)} … 
(equation 1)
a=0,1 disease (OAB and SUI),
E
a: inpatient medical expenditures,
OE
a: outpatient medical expenditures,
O
a: outpatient visit number,
MO: average traffic costs of outpatient visits,
N
a: inpatient number,
M: average traffic costs of inpatient visits
  Indirect costs represent productivity loss resulting from ei-
ther a decrease in the probability of working or in the number 
of hours worked. Indirect costs of disease often constitute a 
substantial part of the estimated costs or savings in economic 
evaluations of healthcare programs. The human capital approach 
is almost unanimously used for estimating indirect costs, and is 
defined as productivity loss due to disease [10]. Therefore, we 
applied the human capital approach in this article among sever-
al potential methods (contingent valuation method and friction 
cost approach).
  Productivity loss cost is the cost of work day loss due to hos-
pitalization for treating illness and work time loss due to visit-
ing the hospital [11]. For estimating productivity loss cost, we 
calculated the work day loss by adding the number of hospital-
ization days and one-third of the hospital visiting days. This 
method is based on the assumption that the productivity for 
one day of hospitalization is similar to that of three cases of out-
patient visits [12].
  In this way, we derived the work day loss and then modified 
it by labor participation rate, which considers employment rate 
and average daily allowance [13,14]. The value of housework 
was also included using the household participation rate and 
average household daily allowance [15].
  In summary, indirect cost was estimated following;
Indirect costs=∑a∑i{(D
a
i+δ×O
a
i)×pi×ei×yi+(D
a
i+δ×O
a
i)
×hi×zi} … (equation 2)
i=0,1,…,n age,
a=0,1 disease (OAB and SUI),
D
a
i: admission day number,
δ: productivity loss ratio of outpatient visit to admission,
O
a
i: outpatient visit number,
pi: labor participation rate,
ei: employment rate,
yi: average daily allowance,
hi: household participation rate,
zi: average household daily allowance
  Intangible costs include the monetary value of pain or suffer-
ing. Although OAB and SUI affect a patient’s quality of life 
[16,17], most economic evaluations avoid estimating intangible 
costs because it is difficult to calculate the value of pain or suf-
fering [18]. Therefore, we only quantified the direct and indi-
rect costs.
Cost Estimation Methods
In overactive bladder patients, direct cost included the subse-
quent physician visit costs, treatment fees, pharmacologic costs 
and traffic costs, while indirect cost included productivity loss   Sung, et al.  •  Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
http://dx.doi.org/10.5213/inj.2012.16.1.23
INJ
www.einj.org    25
cost. Physician visit cost represented the total cost requested to 
the National Health Insurance Cooperation and was calculated 
by using data from the National Health Insurance Review and 
Assessment Service Statistic Team for the patients who were di-
agnosed with OAB (N31, N30, N39.4 of ICD-10). The treatment 
fee included conservative management costs such as electro-
stimulation therapy, biofeedback therapy, and sacral nerve stim-
ulation therapy. Pharmacologic cost was the cost of buying anti-
cholinergics in Korea (tolteridine, propiverine, oxybutinine, 
spagerine, etc.), which was estimated by using the total sales of 
a pharmaceutical company. However, among the pharmacolog-
ic cost, preparation cost was excluded because of the difficulty 
of estimation.
  In SUI patients, direct cost consists of physician visit cost, 
admission cost, surgery cost, and treatment fees and traffic cost, 
while indirect cost includes productivity loss cost. All of these 
costs were calculated by using data from the National Health 
Insurance Review and Assessment Service Statistic Team in pa-
tients who were diagnosed with SUI (N393 of ICD-10) and un-
derwent corrective surgery (R3561, R3562, R3563 in National 
Health Insurance Cooperation request code).
RESULTS
Cost of OAB
The total cost of OAB was 117,452,492,567 KRW during 2006. 
Among the direct costs, the physician visit cost and treatment 
cost totaled 34,811,736,350 KRW, while the pharmacologic cost 
was estimated at 29,700,000,000 KRW and traffic cost was 
11,236,954,050 KRW (Table 1). The indirect costs (productivity 
loss cost) was 41,703,802,167 KRW (Tables 1, 2).
  The total cost of OAB was 145,438,817,568 KRW during 
2007. Among the direct costs, the physician visit cost and treat-
ment cost totaled 46,781,663,000 KRW, while the pharmaco-
logic cost was estimated at 33,306,597,507 KRW and traffic cost 
was 23,653,636,848 KRW (Table 1). The indirect costs (produc-
tivity loss cost) was 41,696,920,213 KRW (Tables 1, 2).
Cost of SUI
The total cost of SUI was 122,005,726,757 KRW during 2006. 
Physician visit cost and treatment cost in the outpatient depart-
ment was 225,021,870 KRW, and admission cost, including 
surgery cost, was estimated at 101,262,394,900 KRW and traffic 
cost was 2,009,247,818 KRW (Table 1). The indirect costs (pro-
ductivity loss cost) was 18,509,063,069 KRW during 2006 (Ta-
bles 1, 3).
  The total cost of SUI was 58,850,214,705 KRW during 2007. 
Physician visit cost and treatment cost in the outpatient depart-
ment was 217,594,700 KRW, and admission cost, including 
surgery cost, was estimated at 50,475,822,280 KRW and traffic 
cost was 1,532,254,968 KRW (Table 1). The indirect costs (pro-
ductivity loss cost) was 6,624,542,757 KRW during 2007 (Tables 
1, 3).
Patient Visits According to Medical Institute Types
The data shows that 79% of OAB patients visited private clinic 
in 2006, and 75% in 2007. Also, 50% of SUI patients visited at 
private clinic in 2006, and 48% in 2007 (Table 4).
Table 1. Total social costs of OAB and SUI (2006, 2007)
Factors
OAB SUI
2006 2007 2006 2007
Direct cost
Medical cost  
Medical expeditures 34,811,736,350 46,781,663,000 101,487,415,870 50,693,416,980
Pharmacologic costs 29,700,000,000 33,306,597,507
Non-medical cost
Traffic expenses 11,236,954,050 23,653,636,848 2,009,247,818 1,532,254,968
Indirect costs
Labor productivity loss 41,703,802,167 41,696,920,213 18,509,063,069 6,624,542,757
Total costs 117,452,492,567 145,438,817,568 122,005,726,757 58,850,214,705
Values are presented as Korean Won (the currency of South Korea) for 2006, 2007. 
OAB, overactive bladder including urge incontinence; SUI, stress urinary incontinence.Sung, et al.  •  Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
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DISCUSSION
The prevalences of OAB and SUI increase with advancing age, 
and the rapid increase of an aged population is associated with 
tremendous costs. The annual socioeconomic cost of OAB in-
creased from 117 billion KRW in 2006 to 145 billion KRW in 
2007; SUI on the other hand decreased from 122 billion KRW 
in 2006 to 59 billion KRW in 2007. Over 75% of OAB patients 
visiting private clinic show the increase of OAB costs which 
may be related to promotional activities such as advertisements 
and awareness campaigns carried out by various academic so-
cieties and pharmaceutical companies for patients and primary 
care physicians. The cost of SUI decreasing in 2007 might be 
linked to the National Health Insurance Review Agency’s raised 
standards for approving patients for SUI surgery. However, to 
find the exact reason for the cost of SUI decreasing in 2007, 
further comparison between 2007 data and subsequent data is 
needed. 
  In the United States (US), the socioeconomic cost for OAB 
and SUI was 24 billion Dollars (USD, United States Dollar) in 
2004 [19]. That figure changed to 2,400 billion KRW according 
to one dollar equal to 1,000 KRW, which is ten times larger than 
the 240 billion KRW in 2005. The causes of this difference are 
noted below. First, differences in the population size and pro-
portion of population aged 65 and over can cause such cost dis-
crepancies. From the Organization for Economic Cooperation 
and Development (OECD) fact book, the total number of peo-
ple in the US was 294,056,000 and that of Korea was 48,138,000 
in 2005. The US population is six times larger than that of Ko-
rea. Moreover, the ratio of people who are older than 65 in US 
is higher than that of Korea (12.4% vs. 9.1%), which makes the 
socioeconomic cost of OAB and SUI different [20]. Second, an-
other considerable cause of differing socioeconomic costs is a 
difference between the two economic scales. According to OECD 
fact book, the gross domestic growth (GDP) of the US was 
12,376 billion USD and that of Korea was 1,027 billion USD in 
2005. Thus, GDP of the US was approximately twelve times 
larger than that of Korea. Third, the differences in study design 
were also responsible for differences in measured cost. For ex-
ample, complications of OAB and SUI (UTI, fracture, dermato-
Table 2. Calculation of the labor productivity loss in patients with OAB (2006, 2007)
Workday loss
Economic  
participation rate
Employment rate
Employment  
allowance
Houseworking  
participation rate
Houseworking  
allowance
2006 (yr)
Age
-20 24,209 0.075 0.896 86,027,553 0 - 
20-29 51,665 0.653 0.923 2,186,926,165 0.347 711,134,282
30-39 98,205 0.755 0.97 7,546,740,022 0.245 1,339,352,525
40-49 137,121 0.795 0.98 12,812,312,465 0.205 1,086,915,102
50-59 117,918 0.701 0.978 9,037,282,682 0.299 1,081,226,392
60-69 139,661 0.379 0.986 4,081,295,359 0.621 1,734,589,620
Total 35,750,584,246 5,953,217,921
2007 (yr)
Age
-20 25,093 0.073 0.907 90,981,259 0 - 
20-29 50,272 0.646 0.929 2,162,947,477 0.354 705,924,105
30-39 96,667 0.753 0.968 7,619,737,230 0.247 1,329,143,611
40-49 146,191 0.799 0.98 14,411,477,515 0.201 1,136,196,452
50-59 144,395 0.712 0.979 12,026,944,367 0.288 1,275,293,696
60-69 177,360 0.386 0.986 5,475,813,623 0.614 2,177,984,893
Total 41,696,920,213 6,624,542,757
Values are presented as Korean Won (the currency of South Korea) for 2006, 2007. 
OAB, overactive bladder including urge incontinence.  Sung, et al.  •  Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
http://dx.doi.org/10.5213/inj.2012.16.1.23
INJ
www.einj.org    27
logic problem, etc.), the cost of incontinence pads, and the cost 
other UI types result in a cost difference between the two coun-
tries. When comparing incidences of OAB and SUI in Korean 
women, the prevalence was 24.3% and SUI was most common 
among the UI patients (48.8%); the prevalence of OAB was 
12.2% in Korea. In the US study, the prevalence of SUI and 
OAB were 10 to 15% and 16.4%, respectively, which is not very 
different from that of Korea. In this study, the cost of OAB and 
SUI was estimated. However, future studies should include oth-
er types of UI (overflow incontinence, etc.), as well as the cost 
of complications from urinary incontinence, and the cost of 
laundry and incontinence pads (or diapers).
  In 2000, Korea became an “aging society” because 7.2% of 
the population were considered elderly. In 2005, the ratio of old 
people increased to 9.1%, and is forecast to be 14.3% by 2018, 
making Korea an “aged society”. Korea is projected to be a su-
Table 3. Calculation of the productivity loss in patients with SUI (2006, 2007)
Workday loss
Economic  
participation rate
Employment rate
Employment  
allowance
Houseworking  
participation rates
Houseworking  
allowance
2006 (yr)
Age
-20 159 0.075 0.896 565,012 0 - 
20-29 1,070 0.653 0.923 45,306,106 0.347 14,732,425
30-39 29,088 0.755 0.97 2,235,294,111 0.245 396,707,294
40-49 100,348 0.795 0.98 9,376,262,827 0.205 795,422,504
50-59 57,201 0.701 0.978 4,383,945,457 0.299 524,498,092
60-69 17,682 0.379 0.986 516,718,801 0.621 219,610,440
Total 16,558,092,314 1,950,970,755
2007 (yr)
Age
-20 89 0.073 0.907 867,754 0 - 
20-29 240 0.646 0.929 19,318,049 0.354 1,646,206
30-39 7,110 0.753 0.968 1,308,221,035 0.247 36,645,459
40-49 25,233 0.799 0.98 6,501,041,156 0.201 59,530,388
50-59 16,287 0.712 0.979 3,612,853,175 0.288 33,548,168
60-69 5,251 0.386 0.986 431,720,699 0.614 6,571,333
Total 11,874,021,870 137,941,555
Values are presented as Korean Won (the currency of South Korea) for 2006, 2007. 
SUI, stress urinary incontinence.
Table 4. Direct costs of OAB and SUI according to types of the medical institutes
Types of the medical institutes
OAB SUI
2006 2007 2006 2007
General hospital (specialized) 33,781 (5) 55,157 (6) 4,938 (8) 3,735 (8)
General hospital 65,441 (9) 113,017 (12) 12,198 (19) 9,572 (20)
Hospital 42,687 (6) 63,141 (7) 15,525 (24) 11,487 (24)
Private clinic 543,745 (79) 695,258 (75) 32,090 (50) 23,164 (48)
Health care institute 3,768 (1) 6,111 (1) 6 (0) 54 (0)
Total 689,422 (100) 932,684 (100) 64,757 (100) 48,012 (100)
Values are represented as Korean Won (%). 
OAB, overactive bladder; SUI, stress urinary incontinence.Sung, et al.  •  Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
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per-aged society in 2026 because the ratio of elderly people will 
be greater than 20% [4]. According to a study of the US in 1995, 
the direct cost of UI was 16 billion USD. It was more than dou-
ble 10 billion USD in 1987, 7 billion USD in 1984, despite price 
rising for ten years. The increase in the ratio of the elderly pop-
ulation, which was more rapid than ever in history, will make 
the prevalence of SUI and OAB also increase; eventually, the 
rate of the cost increase will be greater than that of the US.
  In the US, the prevalence of OAB was 16.9% in women and 
16% in men according to the National Overactive Bladder Eval-
uation program [21]. Furthermore, the OAB cost estimated in 
this study was 12 billion USD, which is comparable to the esti-
mated costs of other illnesses, such as 13.8 billion USD for os-
teoporosis and 11.1 billion USD for gynecologic and breast 
cancer [22].
  Subak et al. [23] reported that women with severe inconti-
nence pay about 900 USD out-of-pocket per year for routine 
incontinence care. Costs increased with incontinence severity. 
Costs were 65% higher for women with urge incontinence com-
pared with those having stress incontinence. Incontinence is as-
sociated with a clinically significant treatment for health-related 
quality of life. Hence, an effective incontinence treatment may 
decrease routine care costs and improve quality of life.
  In the study of OAB complication, male aged OAB patients 
associated with UI are twice as likely to be hospitalized, and 
women are three times as likely. Urge incontinence results in 
anxiety, negative self-recognition, social isolation, and is associ-
ated with depression, other chronic diseases, and risk of suicide 
[24,25]. Old patients are more susceptible to fracture than young 
patients; 50% of patients have a history of fall, and 8.5% of pa-
tients had fracture history upon three year follow-up [26]. UTI 
and skin ulcer were also common.
  However, only 25% of those with OAB visited their doctor 
for bladder reasons in the past years. Also, of the two groups 
with OAB (those with and without incontinence), only 40% of 
those with incontinence visited their doctor for bladder reasons 
during the past year. Furthermore, of those that used inconti-
nence pads, only 45% visited their doctor for bladder problems, 
leaving 55% who probably relied on self-treatment [21]. More 
seriously, 12.6% of those with UI visited their doctor, yet only 
0.8% of those had surgery for incontinence [2]. In Korea, al-
though the consequences associated with OAB and SUI result 
in adverse effects on quality of life and increasing medical cost, 
a very small number patients used medications because of a 
lack of social recognition. 
  As country’s economy develops, quality of life is getting im-
portant to people. Therefore, a demand for incontinence treat-
ment will increase as the number of OAB and SUI patients 
grows. OAB and SUI will generate tremendous expenses, and 
the prevalence of OAB and SUI will continue to increase. In the 
future, the cost of OAB and SUI will also increase, and a signifi-
cant socioeconomic problem may result. Therefore, a social 
counter plan must be designed for decreasing the cost of OAB 
and SUI, as well as a method for efficiently distributing this 
cost.
  OAB and SUI result in an adverse effect on the quality of life. 
The prevalence and socioeconomic costs are higher than osteo-
porosis, chronic obstructive pulmonary disease, cerebrovascu-
lar accident, and diabetes mellitus. Moreover, since Korea is en-
tering rapidly into an aged society, the cost of treating OAB and 
SUI is predicted to increase. An effective rescue or policy might 
be considered for these future socioeconomic costs.
  This study was based on data of the Health Insurance Review 
Agency. So Non-insurance covered was not included according 
to types of the medical institutes. It is a research limitation of 
this study.
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